WEAR - Search Results

The following is an archived video story. The text content of that video story is available below for reference. The original video has been deleted and is no longer available.

American Academy of Neurology does Parkinson disease study

A new report says there may be a link between certain cholesterol lowering drugs and Parkinson’s disease.
This study actually took a closer look at those who had stopped taking certain medications for cholesterol and those who’ve been working with those who have Parkinson’s disease say it's an interesting connection, likely where more research is needed. But it is one that they have potentially seen before.
Doctor Andrew Duker said Parkinson’s is a deficiency of dopamine in the brain --
“..And a deficiency of that causes symptoms such as tremor, slowness, stiffness, balance trouble, falls.”
This study from the American Academy of Neurology -- Specifically looked at fat soluble statin drugs to lower cholesterol --
Duker said, “The biggest association seems to be patients who are taking these statin drugs seem to be less likely to develop Parkinson’s disease, in large groups of people, this is not a cause and effect, but rather an association.
Those in the study who stopped the fat soluble statins were 58 percent more likely to develop Parkinson’s than those who kept taking the drugs.
So there may be benefit to staying on them --for others?
Duker said, “Reducing the risk of Parkinson’s disease, but we don't know fully the implications of it yet.